Asia Business Gazette
SEE OTHER BRANDS

Fresh news on business and economy in Asia and the Pacific

Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on April 15, 2025

Duck Creek Technologies Mengangkat Pensiunan Jenderal AS, Daniel Hokanson sebagai Anggota Direksi

Duck Creek Technologies Mengangkat Pensiunan Jenderal AS, Daniel Hokanson sebagai Anggota Direksi

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, penyedia solusi cerdas yang menggambarkan masa depan industri asuransi harta benda dan aneka (P…

Duck Creek Technologies, 미 예비역 장성으로 주방위군 총감을 지낸 Daniel Hokanson을 이사회에 선임

Duck Creek Technologies, 미 예비역 장성으로 주방위군 총감을 지낸 Daniel Hokanson을 이사회에 선임

보스턴, April 15, 2025 (GLOBE NEWSWIRE) -- 손해보험(P…

Intermex Empowers Store Owners With Launch of Intermex SOMA: A Game-Changing Mobile App for Business Management on the Go

Intermex Empowers Store Owners With Launch of Intermex SOMA: A Game-Changing Mobile App for Business Management on the Go

MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- International Money Express, Inc. (NASDAQ: IMXI), a leading money remittance provider to Latin America and the Caribbean, has officially launched a new mobile platform designed to give Intermex agents real-time …

Duck Creek Technologies Nomeia Daniel Hokanson, General Reformado dos EUA, para seu Conselho Diretor

Duck Creek Technologies Nomeia Daniel Hokanson, General Reformado dos EUA, para seu Conselho Diretor

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- A Duck Creek Technologies, fornecedora de soluções inteligentes que definem o futuro do seguro de propriedade e acidentes (P…

Duck Creek Technologies แต่งตั้งพลเอก Daniel Hokanson ผู้เกษียณอายุราชการจากกองทัพบกสหรัฐฯ…

Duck Creek Technologies แต่งตั้งพลเอก Daniel Hokanson ผู้เกษียณอายุราชการจากกองทัพบกสหรัฐฯ…

บอสตัน, April 15, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies ผู้ให้บริการโซลูชันอัจฉริยะที่กำหนดอนาคตของอุตสาหกรรมประกันวินาศภัย (P…

Duck Creek Technologies 委任美國退役上將 Daniel Hokanson 為董事會成員

Duck Creek Technologies 委任美國退役上將 Daniel Hokanson 為董事會成員

波士頓, April 15, 2025 (GLOBE NEWSWIRE) -- 引領財產與意外險 (P…

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s pipeline diversification beyond BNC210 US $15M milestone payment from Merck extends company’s cash runway to …

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress

NORCROSS, Ga., April 15, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the EASL …

Basetwo Wins Top Prize at CIX Summit 2025, Selected for Startup World Cup

Basetwo Wins Top Prize at CIX Summit 2025, Selected for Startup World Cup

TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Basetwo, an AI platform for manufacturing, has been recognized at the 2025 CIX Summit as the 2025 Canadian Regional Winner, positioning itself to represent Canada at the upcoming Startup World Cup in Silicon …

Extendicare Announces April 2025 Dividend of C$0.042 per Share

Extendicare Announces April 2025 Dividend of C$0.042 per Share

MARKHAM, Ontario, April 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company (the “Common Share”) for the month of April 2025, …

Lisata Therapeutics Announces Research License with Catalent

Lisata Therapeutics Announces Research License with Catalent

BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival

Precise Volume Measurement Prior to Discharge Identifies Mortality Risk Oak Ridge, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced compelling new data …

IPG Photonics to Announce First Quarter 2025 Financial Results on May 6

IPG Photonics to Announce First Quarter 2025 Financial Results on May 6

MARLBOROUGH, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The Company will hold a conference call to review these …

Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir

Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir

FREEHOLD, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, today announced the addition of …

Golden State’s Asset Management Program Expands Offerings and Enhances Advisor Support by Partnering with WealthShield

Golden State’s Asset Management Program Expands Offerings and Enhances Advisor Support by Partnering with WealthShield

SOUTH COAST METRO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Golden State Asset Management (“GSAM”) is pleased to announce a series of strategic enhancements designed to further empower financial advisors and their clients. These initiatives, set to …

Greystone Logistics Reports 3rd Quarter Earnings

Greystone Logistics Reports 3rd Quarter Earnings

TULSA, Okla., April 15, 2025 (GLOBE NEWSWIRE) -- Greystone Logistics (GLGI), the leading manufacturer of recycled plastic pallets and providing sustainable logistics solutions, announces three- and nine-month results for the period ending February 28, 2025 …

Rezolve Ai Secures $9.8 Million Annual Contract with Liverpool Mexico

Rezolve Ai Secures $9.8 Million Annual Contract with Liverpool Mexico

NEW YORK and MEXICO CITY, April 15, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, is proud to announce a landmark $9.8 million yearly contract with Liverpool Mexico, the country’s premier department …

ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer

ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer

In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …

Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions

Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions

SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Pipe, a fintech company enabling embedded financial solutions for software platforms, today announced its strategic acquisition of Glean.ai, a leading AI-powered spend management company. With this …

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025

HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service